Comments (28)

2mo 
Anonymous Chip, what's your opinion? Comment below:

EVR=MOE>PWP>DUC>GHL for Rx imo. Given Ducera was built out by ex PWP and Greenhill folks, pretty sharp and well connected in the distressed space. LA office recently poached several HL Rx bankers at the junior and mid level. If you want to be a career Rx banker and die young, could be a great place. If culture matters, take any of the above over Ducera.

Controversial
  • Associate 1 in PE - Other
2mo 

I wouldn't put Ducera above Moelis/Evercore, but the folks at Ducera have crushed it from inception and it's absolutely a firm on the rise and considered an EB. Would put Ducera RX above Greenhill RX. Ducera's still small but they punch above their weight in the RX space for sure, and the firm has begun getting the recognition it deserves in terms of exit opps at the junior level. I do agree with the comment above that culture leaves something to be desired for, but I think that's more in terms of WLB. They absolutely grind juniors to the bone there, but I haven't heard any horror stories about seniors being dicks/unreasonable to juniors. Definitely a place to work really, REALLY hard, and I would say it's worth it if you can bear the work.

  • 7
  • 12
  • Associate 1 in PE - Other
2mo 

Not sure why I'm getting MS for this comment. I have a good friend who went through Ducera's analyst program and I'm basing my comment on his experience. If anyone has any legitimate counterpoints, list them. Otherwise I'll just assume it's salty GHL interns throwing crap

  • Works at Evercore
2mo 

Evercore RX guy here, and I have friends at both Ducera and Greenhill RX. Personally, I'd argue that Greenhill RX is still a better junior experience overall. From the perspective of a junior, you should be taking the biggest name possible without sacrificing too much experience and personal wellbeing. Greenhill RX will open up far more doors, especially if you have any interest in buy-side (Greenhill punches above its weight class for exits because they have an institutional 2-and-out culture and supporting analysts in leaving). Greenhill RX is pretty sweaty as well, but Ducera is materially sweatier, and at the end of the day Greenhill RX is no slouch in terms of deal flow so you'll still get a good analyst experience.

  • Incoming Analyst in IB - Gen
2mo 

.

  • 1
  • 3
Most Helpful
  • Works at Evercore
2mo 

Greenhill's core senior team led by Augustine is definitely legit in the space. Also, for their size, they've been doing decently in terms of deal flow (checked reorg league tables and they're roughly where Ducera is, and off the top of my head I know they were involved in NAC and also do a lot of advisory work for Carlyle and Apollo with portco RX/distressed M&A/recaps). You also have to keep in mind that Greenhill RX is roughly the same size if not smaller than Ducera, so deal flow per head is still comparable.

Also, from the junior perspective, optionality/brand name is just as important if not more important than deal experience, and Greenhill beats out Ducera by quite a margin there.

  • Associate 1 in PE - Other
2mo 

Laughing at all these pissy Greenhill analysts throwing MS at the thought of Ducera being a better bank, even though it's true (and will become more and more evident in the next couple years as GHL continues to fall down the league tables)

  • 1
  • Analyst 1 in IB - Gen
2mo 

Ducera was #17 in the league tables in 2022 and greenhill was even worse, not even in top 10 IMO

  • Analyst 1 in IB - Gen
2mo 

I.. do work in RX tho.. this is from Reorg's 2022 tables don't shit on me intern

image-20230326122823-1

  • Intern in IB - Gen
2mo 

An associate from there DM'd me on LinkedIn during my summer analyst stint to poach me for FT. Hopped on an "introductory call" and she immediately started grilling me about niche Rx technicals and asking why my gpa is so low (I had a 3.5 at the time). Just bad vibes, red flags everywhere. Going to a BB now instead

  • Intern in IB - Gen
2mo 

i wish i made this up dude lol

2mo 
ichbindeluz, what's your opinion? Comment below:

This sounds spot on. Very similar to my interview experience. 

2mo 
bigdogg2, what's your opinion? Comment below:

Ducera is the below all of those listed and is definitely not an EB. Most juniors there are from non-targets and non-traditional IB backgrounds, which isn't end-all-be-all but says something.

Not in the same universe as PWP/EVR/MOCO. Ducera does basically all creditor mandates, while those guys won't touch creditor stuff unless its for a big deal.

I'd still choose Greenhill over them any day given how bad the Ducera culture is. Despite Greenhill's decline, it still has name recognition and is a well-known investment bank (whereas nobody except credit people know Ducera). Additionally, GHL RX is still solid, Neil Augustine leads it who is very respected in the space.

Those rankings comparing fees / deal wins aren't super helpful since so many RX deals aren't public and won't be included. 

  • 7
  • 5
  • Intern in IB - Gen
2mo 

Possimus omnis earum iure similique. Atque facilis voluptatum omnis culpa a qui. Ipsam mollitia et quos numquam fugiat non rem animi. Est qui aperiam non ut. Assumenda molestiae aut voluptatem in dolores sed similique officiis.

Start Discussion

Career Advancement Opportunities

June 2023 Investment Banking

  • Lincoln International (▲01) 99.6%
  • Jefferies & Company (▽01) 99.1%
  • Financial Technology Partners (= =) 98.7%
  • William Blair (▲11) 98.2%
  • Lazard Freres (+ +) 97.8%

Overall Employee Satisfaction

June 2023 Investment Banking

  • William Blair (▲04) 99.5%
  • Lincoln International (▲11) 99.1%
  • Canaccord Genuity (▲18) 98.6%
  • Stephens Inc (▲12) 98.2%
  • Financial Technology Partners (▲09) 97.7%

Professional Growth Opportunities

June 2023 Investment Banking

  • Lincoln International (▲01) 99.5%
  • Financial Technology Partners (▲06) 99.1%
  • Jefferies & Company (▽02) 98.6%
  • Lazard Freres (▲15) 98.2%
  • UBS AG (▲19) 97.7%

Total Avg Compensation

June 2023 Investment Banking

  • Director/MD (6) $592
  • Vice President (32) $396
  • Associates (148) $260
  • 3rd+ Year Analyst (11) $198
  • 1st Year Analyst (279) $170
  • 2nd Year Analyst (91) $170
  • Intern/Summer Associate (46) $166
  • Intern/Summer Analyst (206) $93